Skip to main content
. 2005 Mar 19;330(7492):644–648. doi: 10.1136/bmj.330.7492.644

Table 1.

The objectives for the five phases of monitoring

Phase Monitoring objectives Optimal interval
Pretreatment Check need for treatment Establish a baseline for determining response and change Short—based on variability within patients
Initial titration Assess individual response to treatment Assess immediate adverse effects Achieve control Medium—based on pharmacokinetics (such as drug half life) and pharmacodynamics (physiological impact time) (wash-in)
Maintenance Detect drift from control limits Detect long term harms Long—based on rate of random and systematic “drift”
Re-establish control Bring level back within control limits Medium—as above
Cessation Check safety of cessation Medium—as above